These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19523823)

  • 21. Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors.
    Bhuyan BJ; Mugesh G
    Org Biomol Chem; 2011 Mar; 9(5):1356-65. PubMed ID: 21186397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiotensin converting enzyme inhibitors].
    Sramko M; Remko M
    Ceska Slov Farm; 2006 Jul; 55(4):160-7. PubMed ID: 16921734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of angiotensin I-converting enzyme.
    Sturrock ED; Natesh R; van Rooyen JM; Acharya KR
    Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme.
    Sharma RK; Douglas RG; Louw S; Chibale K; Sturrock ED
    Biol Chem; 2012 May; 393(6):485-93. PubMed ID: 22628311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Size of the aliphatic chain of sodium houttuyfonate analogs determines their affinity for renin and angiotensin I converting enzyme.
    Yuan L; Wu J; Aluko RE
    Int J Biol Macromol; 2007 Aug; 41(3):274-80. PubMed ID: 17467790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.
    Laggner H; Hermann M; Esterbauer H; Muellner MK; Exner M; Gmeiner BM; Kapiotis S
    J Hypertens; 2007 Oct; 25(10):2100-4. PubMed ID: 17885553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms.
    Tzakos AG; Galanis AS; Spyroulias GA; Cordopatis P; Manessi-Zoupa E; Gerothanassis IP
    Protein Eng; 2003 Dec; 16(12):993-1003. PubMed ID: 14983080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors.
    Jallapally A; Addla D; Bagul P; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2015 Jul; 23(13):3526-33. PubMed ID: 25922179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential.
    Manikandan A; Moharil P; Sathishkumar M; Muñoz-Garay C; Sivakumar A
    Eur J Med Chem; 2017 Dec; 141():417-426. PubMed ID: 29032034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis and antihypertensive activity of (+/-)7,8-dihydroxy-3-methyl-isochromanone-4.
    Liu J; Ren H; Xu J; Bai R; Yan Q; Huang W; Wu X; Fu J; Wang Q; Wu Q; Fu R
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1822-4. PubMed ID: 19233642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant food-derived Angiotensin I converting enzyme inhibitory peptides.
    Guang C; Phillips RD
    J Agric Food Chem; 2009 Jun; 57(12):5113-20. PubMed ID: 19449887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII.
    Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L
    Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin I-converting enzyme inhibitory peptide derived from glycinin, the 11S globulin of soybean (Glycine max).
    Mallikarjun Gouda KG; Gowda LR; Rao AG; Prakash V
    J Agric Food Chem; 2006 Jun; 54(13):4568-73. PubMed ID: 16786999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers.
    Kalavagunta PK; Bagul PK; Jallapally A; Kantevari S; Banerjee SK; Ravirala N
    Eur J Med Chem; 2014 Aug; 83():344-54. PubMed ID: 24980116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.